Skip to content

Hybrid Osteoplasty Versus Osteotomy in Rhinoplasty

Aesthetic and Functional Outcomes Following Hybrid Osteoplasty Versus Traditional Osteotomy in Rhinoplasty: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07142525
Enrollment
200
Registered
2025-08-26
Start date
2025-10-01
Completion date
2026-12-01
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinoplasty Techniques

Keywords

Osteoplasty, Dorsal Hump, Rhinoplasty

Brief summary

This study is designed to compare two common techniques for reducing the nasal hump during rhinoplasty: the traditional method using osteotomes and rasps, and a newer technique called hybrid osteoplasty that uses a surgical drill. Both approaches aim to improve the appearance and function of the nose. The trial will measure pain, swelling, bruising, and the smoothness of the nasal bridge, as well as patient satisfaction and breathing outcomes. Participants will be followed for one year to assess both early healing and long-term results.

Detailed description

This prospective randomized controlled trial will evaluate the aesthetic and functional outcomes of hybrid osteoplasty using a surgical burr compared with traditional osteotomy and rasping in primary open rhinoplasty patients presenting with dorsal humps. The study population consists of adults without prior nasal surgery, trauma, or congenital deformities. Patients are randomized into two groups: Group A (hybrid osteoplasty) and Group B (traditional osteotomy plus rasping). The primary objective is to assess differences in postoperative pain, edema, ecchymosis, dorsal smoothness, contour regularity, and patient satisfaction. Secondary outcomes include functional improvement measured by the Nasal Obstruction Symptom Evaluation (NOSE) score, aesthetic satisfaction assessed by the Rhinoplasty Outcome Evaluation (ROE), and the rate of revision surgery within 12 months. Follow-up assessments are scheduled on postoperative Days 1, 2, and 7, and at 1, 3, 6, and 12 months. Standardized photographic documentation will support aesthetic evaluation, while clinical scoring systems will provide objective and subjective outcome data. The trial is powered to identify whether hybrid osteoplasty offers advantages in contour refinement and reduced soft tissue trauma compared with conventional osteotomy-based approaches.

Interventions

PROCEDUREHybrid Osteoplasty

Open rhinoplasty with dorsal hump reduction performed using a powered surgical burr under irrigation and direct visualization. Bone is contoured gradually to achieve a smooth dorsum while preserving the keystone area. No dorsal osteotomy is performed in this arm. Cartilaginous work and adjunctive steps (e.g., septoplasty or tip refinement) are performed as clinically indicated but are not part of the intervention being tested.

PROCEDURETraditional Osteotomy and Rasping

Open rhinoplasty using the conventional technique for dorsal hump reduction. The bony hump is resected with a straight osteotome, followed by manual rasping to refine the nasal dorsum, with preservation of the keystone area. Powered burrs are not used for primary dorsal contouring in this arm. Cartilaginous work and adjunctive procedures may be performed as clinically indicated but are not part of the tested intervention.

Sponsors

University of Sulaimani
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary open rhinoplasty planned. * Dorsal hump with bony or mixed component suitable for either technique. * No prior nasal surgery or significant nasal trauma affecting dorsum. * ASA I-III and fit for general anesthesia. * Willing to provide written informed consent, including standardized photography. * Able and willing to attend all follow-up visits through 12 months.

Exclusion criteria

* Revision rhinoplasty or prior osteotomy/osseocartilaginous work. * Active infection, open lesions, or uncontrolled dermatologic conditions at operative field. * Bleeding diathesis, platelet disorder, INR elevation, or anticoagulant/antiplatelet therapy that cannot be paused. * Uncontrolled systemic disease (e.g., hypertension, diabetes) or ASA ≥ IV. * Pregnancy or breastfeeding. * Chronic isotretinoin use within past 6 months or long-term systemic corticosteroid use. * Concurrent interventional study that may affect healing or outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in Rhinoplasty Outcome Evaluation (ROE) Score from Baseline to 12 MonthsBaseline (preoperative) and 12 months post-operation.ROE (Rhinoplasty Outcome Evaluation) questionnaire scored 0-100 (higher = greater satisfaction). Score calculated per instrument guidance from the 6 items, converted to 0-100. Change is 12-month minus preoperative score.
Mean Dorsal Contour Irregularity Score on Blinded Photographic Assessment at 12 Months12 months post-operation.Standardized 7-view photographs rated by three blinded surgeons using a 4-point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe irregularity). Primary analysis compares group means; inter-rater agreement assessed.
Mean Periorbital Edema Score on 4-Point Clinician Scale at Day 1 and Day 7Post-op Day 1 and Day 7.3 Clinicians-rated 4-point edema scale (0 = none, 1 = mild, 2 = moderate, 3 = severe).
Mean Periorbital Ecchymosis Score on 4-Point Clinician Scale at Day 1 and Day 7Post-op Day 1 and Day 7.3 Clinician-rated 4-point ecchymosis scale (0-3).
Proportion of Participants with Residual Hump or Dorsal Depression on Blinded Photographic Assessment at 12 Months12 months post-operationBlinded photographic assessment for remnant hump or depression (present/absent), by 3 assessors.
Proportion of Participants with Nasal Dorsum Width Symmetry at 12 Months12 months post-operationSymmetry rated by 3 blinded assessors on 3-point scale (symmetric / mildly asymmetric / asymmetric)
Number of Participants Requiring Unplanned Revision Surgery within 12 MonthsWithin 12 months post-operationAny unplanned surgical revision related to the nasal dorsum

Secondary

MeasureTime frameDescription
Proportion of Participants with Smooth Nasal Dorsum (Non-Blinded Binary Assessment) at 12 Months12 months post-operationSmooth vs Irregular, reported by 3 assessors
Mean Change in Nasal Obstruction Symptom Evaluation (NOSE) Score from Baseline to 12 MonthsBaseline (preoperative) and 12 months post-operation.NOSE questionnaire scored 0-100 (higher = worse obstruction). Change is 12-month minus preoperative score; negative values indicate improvement.
Mean Pain Score on 0-10 Visual Analogue Scale at Post-Op Day 0 and Day 7Post-op Day 0 and Day 7Pain measured on a 0-10 visual analogue scale (higher = more pain)
Proportion of Participants with Palpable or Visible Dorsal Callus on Clinical Exam at 3 and 6 Months3 and 6 months post-operationPresence of palpable or visible dorsal callus on clinical exam (Yes/No). 3 assessors.

Countries

Iraq

Contacts

STUDY_CHAIRGoran L Omer, PhD

University of Sulaimani

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026